Tempus AI EPS - Earnings per Share 2023-2024 | TEM

Tempus AI annual and quarterly earnings per share history from 2023 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Tempus AI EPS for the quarter ending September 30, 2024 was $-0.46, a 55.34% decline year-over-year.
  • Tempus AI EPS for the twelve months ending September 30, 2024 was $-8.79, a 179.94% increase year-over-year.
  • Tempus AI 2023 annual EPS was $-5.3, a 26.19% increase from 2022.
  • Tempus AI 2022 annual EPS was $-4.2, a INF% decline from .
  • Tempus AI annual EPS was $0, a NAN% decline from .
Tempus AI Annual EPS
2023 $-5.30
2022 $-4.20
Tempus AI Quarterly EPS
2024-09-30 $-0.46
2024-06-30 $-6.86
2024-03-31 $-1.47
2023-12-31 $0.00
2023-09-30 $-1.03
2023-06-30 $-1.07
2023-03-31 $-1.04
2022-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.393B $0.321B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Inspire Medical Systems (INSP) United States $5.669B 176.81
Hims & Hers Health (HIMS) United States $5.506B 140.00
IRhythm Technologies (IRTC) United States $2.799B 0.00
Enovis (ENOV) United States $2.475B 16.78
Privia Health (PRVA) United States $2.357B 196.40
Azenta (AZTA) United States $2.286B 122.05
Omnicell (OMCL) United States $2.053B 67.15
10x Genomics (TXG) United States $1.718B 0.00
Clover Health Investments (CLOV) United States $1.568B 0.00
Schrodinger (SDGR) United States $1.486B 0.00
Phreesia (PHR) United States $1.464B 0.00
Butterfly Network (BFLY) United States $0.846B 0.00
Standard BioTools (LAB) United States $0.651B 0.00
Fulgent Genetics (FLGT) United States $0.563B 0.00
Talkspace (TALK) United States $0.529B 0.00
Definitive Healthcare (DH) United States $0.476B 82.40
Health Catalyst (HCAT) United States $0.446B 0.00
TruBridge (TBRG) United States $0.297B 86.52
Pulmonx (LUNG) United States $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
EUDA Health Holdings (EUDA) Singapore $0.114B 0.00
American Well (AMWL) United States $0.108B 0.00
P3 Health Partners (PIII) United States $0.090B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
CareCloud (CCLD) United States $0.062B 0.00
Outset Medical (OM) United States $0.061B 0.00
111 (YI) China $0.054B 0.00
Zepp Health (ZEPP) China $0.043B 0.00
Zhongchao (ZCMD) China $0.043B 0.00
SHL Telemedicine (SHLT) Israel $0.041B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Precipio (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00